Anticancer activities of natural and synthetic peptides

Medicine and Dentistry

• Antineoplastic Activity 100%
• Cancer Cell 100%
• Cancer Therapy 33%
• Chemokine 33%
• Clinical Trial 66%
• Immune Response 66%
• Liposome 33%
• Malignant Neoplasm 33%
• Nanoparticle 33%
• Neoplasm 33%
• Oncolytic Virus 33%
• Peptide Sequence 33%
• Regulatory T Cell 33%
• Synthetic Peptide 100%
• T Cell 33%
• Target Cell 33%

Keyphrases

• Anticancer Activity 100%
• Anticancer Immune Response 7%
• Anticancer Peptides 100%
• Cancer Cells 23%
• Cancer Patients 7%
• Cancer Treatment 7%
• Cationic Amphipathic Peptides 7%
• Chemokine Genes 7%
• Clinical Trials 7%
• Computer Modeling 7%
• Danger Signals 7%
• Fusogenic Liposomes 7%
• Immune Regulation 7%
• In Cancer 15%
• Long-term Benefit 7%
• Mechanism of Action 7%
• Nanoparticle Liposomes 7%
• Natural Peptides 100%
• Novel Treatments 7%
• Oncolytic Virus 7%
• Overall Benefit 7%
• Patient Survival 7%
• Peptide Selectivity 7%
• Peptide Sequencing 7%
• Peptide-based 7%
• Phase I Clinical Trial 7%
• Regulatory T (Treg) Cells 7%
• Safety Benefits 7%
• Sequence Modification 7%
• Synthetic Peptides 100%
• T Cell Immune Response 7%
• Treatment Strategy 7%
• Tumor Targeting 7%

Biochemistry, Genetics and Molecular Biology

• Anticancer 100%
• Antineoplastic Activity 100%
• Cancer Cell 21%
• Chemokine 7%
• Clinical Trial 14%
• Computer Model 7%
• Immune Response 14%
• Peptide Sequence 7%
• Regulatory T Cell 7%
• T Cell 7%
• Target Cell 7%